InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Mehalick David, Chairman & CEO. Director active across 1 companies, notably Coeptis Therapeutics Inc.. Cumulatively, 2 reports have been published. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
1,200,000 shares
Common Stock
SEC:0001683168-21-005808·
1,200,000 shares
Common Stock
SEC:0001683168-21-005808:0·
2 of 2 declarations
About Mehalick David
David Mehalick is the CEO and President of Coeptis Therapeutics Inc. As the leader of the company, he is responsible for setting the strategic vision and overseeing daily operations. His role is crucial in guiding the company within the biotechnology sector, ensuring innovation and growth.
